Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;143(1):82-91.
doi: 10.1111/acps.13239. Epub 2020 Nov 24.

Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort

Ophelia Godin  1   2   3   1 , Marion Leboyer  1   2   3   1 , Raoul Belzeaux  1   4   5 , Frank Bellivier  1   6 , Joséphine Loftus  1   7 , Philippe Courtet  1   8   9 , Caroline Dubertret  1   10   11 , Sebastien Gard  1   12 , Chantal Henry  13 , Pierre-Michel Llorca  1   14 , Raymund Schwan  1   15 , Christine Passerieux  1   16 , Mircea Polosan  1   17 , Ludovic Samalin  1   14 , Emilie Olié  1   5 , Bruno Etain  1   6 ; FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators
Collaborators, Affiliations

Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort

Ophelia Godin et al. Acta Psychiatr Scand. 2021 Jan.

Abstract

Objective: Non-Alcoholic fatty liver disease (NAFLD) is becoming the most common liver disease in Western populations. While obesity and metabolic abnormalities are highly frequent in bipolar disorders (BD), no studies have been performed to estimate the prevalence of NALFD in individuals with BD. The aim of our study is to estimate the prevalence of NAFLD and to identify the potential associated risk factors in a large sample of BD individuals.

Methods: Between 2009 and 2019, 1969 BD individuals from the FACE-BD cohort were included. Individuals with liver diseases, Hepatitis B or C, and current alcohol use disorders were excluded from the analyses. A blood sample was drawn from participants. Screening of NAFLD was determined using fatty liver index (FLI). Individuals with FLI> 60 were considered as having NAFLD.

Results: The prevalence of NAFDL in this sample was estimated at 28.4%. NAFLD was observed in 40% of men and 21% of women. NAFLD was independently associated with older age, male gender, sleep disturbances, and current use of atypical antipsychotics or anxiolytics. As expected, the prevalence of NALFD was also higher in individuals with overweight and in those with metabolic syndrome.

Conclusions: This study reinforces the view that individuals with BD are highly vulnerable to metabolic and cardiovascular diseases. The prevalence of NAFLD in individuals with BD was two times higher than the prevalence reported in the general population. The regular screening of the MetS in individuals with BD should be therefore complemented by the additional screening of NAFLD among these vulnerable individuals.

Keywords: fatty liver disease; liver diseases; metabolic abnormalities; psychiatric disorders.

PubMed Disclaimer

References

    1. Merikangas KR, Akiskal HS, Angst J et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64:543-552.
    1. Management of Physical Health Conditions in Adults with Severe Mental Disorders. World Health Organization; 2018. http://www.ncbi.nlm.nih.gov/books/NBK534487/. Accessed February 11, 2020
    1. Correll CU, Solmi M, Veronese N et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry Off J World Psychiatr Assoc WPA 2017;16:163-180.
    1. Chang C-K, Hayes RD, Perera G et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One 2011;6:e19590.
    1. Vancampfort D, Vansteelandt K, Correll CU et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013;170:265-274.

Publication types